Birgit Krewer Selected Research

CC 1065

3/2009	Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.
1/2007	Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Birgit Krewer Research Topics

Disease

10	Neoplasms (Cancer) 09/2010 - 01/2007

Drug/Important Bio-Agent (IBA)

8	ProdrugsIBA 09/2010 - 05/2008
5	Biological ProductsIBA 03/2009 - 01/2007
4	DuocarmycinsIBA 09/2010 - 01/2007
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2009 - 01/2007
4	EnzymesIBA 09/2009 - 01/2009
2	Monoclonal AntibodiesIBA 12/2009 - 09/2009
2	Pharmaceutical PreparationsIBA 09/2009 - 01/2008
2	CC 1065IBA 03/2009 - 01/2007
2	duocarmycin SAIBA 01/2009 - 05/2008
2	Cholecystokinin B ReceptorIBA 05/2008 - 01/2008
2	Pentagastrin (Peptavlon)FDA Link 05/2008 - 01/2008
1	Glycoside Hydrolases (Endoglycosidases)IBA 12/2009
1	Cholecystokinin (Pancreozymin)IBA 05/2008
1	Immunotoxins (Immunotoxin)IBA 05/2008
1	beta-AlanineIBA 01/2008
1	TetragastrinIBA 01/2008
1	Peptides (Polypeptides)IBA 01/2008
1	EstersIBA 01/2008

Therapy/Procedure

8	Therapeutics 12/2009 - 01/2008